Is It Time to Replace the Tuberculin Skin Test With a Blood Test?
Authors:
- Philip A. LoBuePLPhilip A. LoBue
- Kenneth G. CastroKCKenneth G. Castro
- 18 July 2012
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 308 (3) , 241-242
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Modelling tuberculosis trends in the USAEpidemiology and Infection, 2012
- Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2012
- Questionable Effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a Screening Tool in Healthcare WorkersInfection Control & Hospital Epidemiology, 2010
- Serial testing with the interferon-γ release assay in Portuguese healthcare workersInternational Archives of Occupational and Environmental Health, 2010
- Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.2010
- Interferon-gamma Release Assays (IGRAs) In Serial Testing For Latent Tuberculosis Infection In U.S. Health Care Workers2010
- Cost-effectiveness of Interferon Gamma Release Assays vs Tuberculin Skin Tests in Health Care WorkersArchives of internal medicine (1960), 2009
- Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.2008
- Systematic Review: T-Cell–based Assays for the Diagnosis of Latent Tuberculosis Infection: An UpdateAnnals of Internal Medicine, 2008
- Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.2000